Patent classifications
C
C12
C12N
2770/00
C12N2770/00011
C12N2770/20011
C12N2770/20041
C12N2770/20044
C12N2770/20044
VACCINES AGAINST CORONAVIRUS AND METHODS OF USE
Disclosed herein are nucleic acid molecules encoding a SARS-CoV-2 spike antigen. SARS-CoV-2 spike antigens, immunogenic compositions, and vaccines and their use in inducing immune responses and protecting against or treating a Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection in a subject.